Document is current
Any future updates will be listed below
-
Authors
Szpakowska, Martyna https://orcid.org/0000-0002-5659-8377
Decker, Ann M.
Meyrath, Max https://orcid.org/0000-0001-8585-0474
Palmer, Christie B.
Blough, Bruce E.
Namjoshi, Ojas A.
Chevigné, Andy https://orcid.org/0000-0003-4768-6743
-
Funding
Funding for this research was provided by:
Fonds National de la Recherche Luxembourg (15/10358798)
Fonds National de la Recherche Luxembourg (19/14209621)
Fonds National de la Recherche Luxembourg (PRIDE-11012546)
Fonds National de la Recherche Luxembourg (3004509)
Fonds National de la Recherche Luxembourg (14616593)
Fonds National de la Recherche Luxembourg (18/13255064)
Fonds National de la Recherche Luxembourg (20/15084569)
Fonds National de la Recherche Luxembourg (15/10358798)
Fonds National de la Recherche Luxembourg (3004509)
Fonds De La Recherche Scientifique - FNRS (7.4593.19)
Fonds De La Recherche Scientifique - FNRS (7.4529.19)
Fonds De La Recherche Scientifique - FNRS (7.8504.20)
European Commission (MSCA-ITN-2019-ETN)
- License Information
-
More Information
Article History
Received: 30 September 2020
Revised: 5 February 2021
Accepted: 5 March 2021
First Online: 2 June 2021
Competing interests
: A patent application has been filed on Novel Selective ACKR3 Modulators And Uses Thereof (Applicant: Luxembourg Institute of Health and RTI International).
